American Society of Hematology

ASH Global Research Award

The deadline to submit a Letter of Intent has now passed.

The ASH Global Research Award is the Society’s newest award, designed to support future international scientific leaders, increase hematology capacity, and nurture global collaboration. The award is intended to support hematologists between completion of training and the establishment of their independent careers.

The Global Research Award promises to be accessible to individuals across geographical regions. Proposals will be categorized by home country and classification of country using the United Nations Human Development Index; and applicants will only compete with those in their same classification.

If you have questions about the award or the application process, contact the ASH Awards Department at awards@hematology.org.

Timeline

Application process opens for Letters of IntentMarch 2017
Letter of Intent deadline
Applicants can request assistance with identifying mentors as they complete the LOI
August 31, 2017, 11:59 p.m. Pacific Time
Invitations issued to approved applicantsDecember 2017
Application deadlineMay 1, 2018
Award winners notifiedJuly 2018
back to top

Program Benefits

The award length may vary from six months to three years depending on the proposed project need. Award size will vary and is intended to be flexible. The amount requested in the application will be assessed to determine whether it is appropriate for the project and for the costs of the region.

Program Objectives

  • Support the hematology-focused careers of ASH members at the trainee and early investigator career stages based in countries other than the United States or Canada.
  • Foster an inclusive scientific community through a program that seeks to support leaders from all regions of the globe.
  • Offer an award with a funding structure that accommodates a wide array of innovative hematology-related project based applications.
  • Provide support for training, including training in the conduct of clinical trials, as well as support for the conduct of research.
  • Strive to have 50 percent of the projects supported be relevant to non-malignant hematology.
back to top

Supported Projects

The following types of projects will be considered:

  • Hematology research, including basic, translational, patient-oriented, and outcomes-based research
  • Requests for training at other institutions by trainees or early-career investigators, pilot studies, collaborative projects, and other proposals for career development

Examples of potential projects include, but are not limited to:

  • Projects advancing the diagnostic capabilities or therapeutic care delivery of hematological illnesses in developing regions
  • Projects addressing hematological illnesses of high incidence and impact in the applicant’s home region
  • Projects incorporating cross-disciplinary collaborations aimed at enhancing regional scientific and care capabilities for hematologic illnesses
  • Projects enhancing career development of individuals who will play future leadership roles in regional scientific and care delivery roles for hematologic illnesses

Basic Research

ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, hematopoietic cells, and samples obtained from human patients or from vertebrate animal models. For the purpose of this grant, hematology-related basic research is designed to further our understanding of the blood, bone marrow, and related organs, and/or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.

Translational Research

ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials.

Patient-Oriented Clinical Research

Patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: mechanisms of human disease, therapeutic interventions, clinical trials, and development of new technologies.

Outcomes-Based Research

Options for outcomes-based research include: a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology; survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions; retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health-care policy decisions related to hematologic disease; and large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.

Applications that fall within any of the categories discussed above are encouraged.

back to top

Eligibility Requirements

The following individuals are eligible to apply:

  • Early-career ASH International members
    • MD graduation may be no more than 16 years prior to application, or the applicant may have no more than 10 years of post-doc experience after PhD graduation.
    • Applicants holding both MD and PhD degrees must be within 16 years of MD graduation.
    • PhD students should have at least one year of experience at the time of application.

Not an ASH member yet? Take the first step. Global Research Award applicants must be ASH members in good standing at the time of the application deadline; and membership must be maintained for the duration of the award term.

Applicants from low and middle human development countries (per the United Nations Human Development Index) can apply for a one-time, needs-based grant to fund the cost of a one year ASH membership. This can be found on the Letter of Intent form.

Requests for Exception

Individuals who do not meet the aforementioned eligibility criteria may submit a request for exception with a justification for extenuating circumstances. Examples include but are not limited to:

  • Exceptions for applicants in regions where hematology-focused training programs are limited but there is a proposal for a hematology-related project
  • Exceptions for applicants who exceed the maximum years post-graduation but have extenuating circumstances

There are no limits on the number of applicants allowed per institution or laboratory; however, in the interest of programmatic balance, only one award per institution or laboratory will be granted each year.

Investigators who are principally employed by pharmaceutical or biotechnology companies are not eligible to apply.

back to top

Mentorship

The Global Research Award requires that all applicants have a local mentor and a global mentor. The global mentor must be an ASH Active or International member in a region or country outside of the applicant’s region or country of residence.

Applicants who are invited to submit a full proposal will be asked to collaborate with both mentors in the development of their application. The nature of the mentor relationship will be defined by the applicant and mentors, as the program will maintain a flexible approach to mentorship. However, the global mentor is expected to interact with the award recipient and local mentor a minimum of four times per year for at least three years. ASH will periodically engage the mentors to ensure that program mentorship objectives are being met.

Request Assistance in Identifying a Mentor

Applicants will be asked about their mentorship needs during the Letter of Intent process. Applicants can indicate that they have already identified their required mentors, or they may request assistance in doing so. ASH will work to identify mentors for invited applicants in response to requests in the Letters of Intent.

back to top

Application Process

The application process is a two-step process. Eligible applicants must first submit a Letter of Intent. Select applicants will then be invited to submit a full proposal. All applications and supporting documents must be submitted through ASH’s online awards module.

Letter of Intent Requirements

Eligible applicants must submit the following (in English):

  • A 700-word narrative of the proposed project, including:
    • Key project goals
    • Description of the project and scientific focus/relevance
    • Description of approach
    • Description of initial plans for the overall mentorship team
  • A 200-word description of the applicant’s career level, addressing the following topics:
    • Where the applicant is in his/her career
    • What the applicant’s level of training is relative to the training structure of his/her home country
    • What the applicant’s plan is for completion of training
  • A biographical sketch (or equivalent)
back to top

Evaluation, Selection, and Notification

Reviewers will assess all submitted Letters of Intent and select the applicants who will be invited to submit a full proposal. Based on the requests made by the applicants, the program subcommittee will match and introduce the selected applicants to mentors. Invited applicants will be provided any project specific questions that should be answered in addition to the application questions.

ASH will review all completed applications submitted by the application deadline and will select the applicants to be funded. Application decisions and critiques will be sent to all applicants.

back to top

Questions

For questions about the award or the application process, please contact the ASH Awards Department at awards@hematology.org. back to top